Finnish Life Sciences Stock News

First quarter earnings put Metsä Board Oyj (HLSE:METSB) under closer scrutiny Metsä Board Oyj (HLSE:METSB) has drawn renewed attention after first quarter 2026 results showed sales of €393.7 million compared with €480.8 million a year earlier, with net loss widening to €16.7 million and basic loss per share at €0.04. See our latest analysis for Metsä Board Oyj. Despite the weak first quarter, Metsä Board Oyj’s share price shows mixed momentum, with a 12.36% 90 day share price return...

Sampo Oyj (HLSE:SAMPO) held its AGM on 22 April 2026, approving a €0.36 per share dividend for 2025. This decision puts income potential and capital allocation in focus for shareholders. See our latest analysis for Sampo Oyj. Despite the AGM decisions, Sampo Oyj’s share price has eased in recent months, with a 30 day share price return of a 4.37% decline and a year to date share price return of a 13.57% decline, while the 5 year total shareholder return of 65.29% points to stronger longer...

Konecranes (HLSE:KCR) shares are in focus after first quarter 2026 results showed lower sales and net income year on year, while management reaffirmed full year guidance and highlighted a new shipyard crane order from Meyer Turku. See our latest analysis for Konecranes. The share price reaction has been mixed, with a 7.21% 1 day share price return after the results, set against a 19.17% 90 day share price decline and a 46.47% 1 year total shareholder return that points to longer term...

Some Fiskars Oyj Abp ( HEL:FSKRS ) shareholders may be a little concerned to see that the Independent Non-Executive...

Huhtamäki Oyj (HLSE:HUH1V) stock has been reacting to Q1 2026 results, where the adjusted EBIT margin reached 10% and cash flow was strong, even as sales and net income were lower year on year. See our latest analysis for Huhtamäki Oyj. At a share price of €27.26, Huhtamäki Oyj has seen a 1-day share price return of 1.3% decline and a year to date share price return of 8.5% decline. The 1-year total shareholder return of 13.3% decline points to fading momentum despite the Q1 2026 margin...

The quarterly results for UPM-Kymmene Oyj ( HEL:UPM ) were released last week, making it a good time to revisit its...

What the latest earnings tell you about Hiab Oyj (HLSE:HIAB) Hiab Oyj (HLSE:HIAB) opened the quarter with earnings that showed lower sales and net income. This development can quickly influence sentiment if you hold or track the stock closely. See our latest analysis for Hiab Oyj. Despite the weaker quarter, Hiab Oyj’s share price has shown positive momentum recently, with a 1 month share price return of 20.83% and a year to date share price return of 2.24%, while the 1 year total shareholder...

Nokian Renkaat Oyj (HLSE:TYRES) shares are in focus after the company reported first quarter 2026 results showing higher sales and a smaller net loss, while also reiterating full year guidance for revenue growth and an 8% to 10% operating margin. See our latest analysis for Nokian Renkaat Oyj. The earnings update and reiterated 2026 guidance come after a 12.4% 1 month share price return and an 8.5% year to date share price gain, while the 1 year total shareholder return of 58.4% contrasts...

Earnings event and why it matters for Alma Media Oyj (HLSE:ALMA) Alma Media Oyj (HLSE:ALMA) has just reported first quarter 2026 results, with sales of €83.1 million and net income of €15.7 million, alongside higher basic and diluted earnings per share from continuing operations. See our latest analysis for Alma Media Oyj. The recent Q1 earnings release and board reorganisation came against a softer backdrop for the shares, with a 90 day share price return of a 9.42% decline and a year to...

Tieto Oyj (HLSE:TIETO) is back in focus after a reported 4 percentage point improvement in adjusted EBITA to 14.7%, coupled with fresh interim leadership appointments to support its ongoing transformation. See our latest analysis for Tieto Oyj. The share price reaction has been positive in the short term, with a 1-day share price return of 4.22% and 7-day share price return of 3.83% around the €19.0 level. However, the 1-year total shareholder return of 28.36% contrasts with weaker 3 and 5...

Terveystalo Oyj reported past first-quarter 2026 results showing sales of €308.2 million and net income of €17.2 million, both lower than a year earlier, with basic earnings per share from continuing operations falling to €0.14. Management also issued cautious guidance that profitability in the first half of 2026 will trail the first half of 2025, sharpening investor focus on how quickly the business can restore earnings momentum. With profitability in early 2026 expected to underperform...

Even though Verkkokauppa.com Oyj ( HEL:VERK ) posted strong earnings, investors appeared to be underwhelmed. Our...

Neste Oyj ( HEL:NESTE ) defied analyst predictions to release its first-quarter results, which were ahead of market...

Wondering if Nordea Bank Abp at €15.99 still offers value or if most of the opportunity is already priced in? This article walks through the key signals that matter for you. The share price has moved 2.0% over the last week and 5.6% over the last month, with a 37.9% return over 1 year and 105.8% over 3 years, while year to date it is down 2.3%. Recent coverage around Nordea Bank Abp has focused on its position within the wider European banking sector and how investors are weighing interest...

Why Kemira Oyj (HLSE:KEMIRA) is back on investors’ radar Kemira Oyj (HLSE:KEMIRA) has drawn fresh attention after first quarter 2026 results showed lower sales and net income than a year earlier, alongside new full year 2026 revenue guidance. See our latest analysis for Kemira Oyj. The 1-day share price return of 3.0% to €17.65 comes after a weaker first quarter and a new 2026 revenue range, while a 30-day share price decline of 8.6% contrasts with a 5-year total shareholder return of 56.7%...

Orion Oyj has started a Phase 1b/2 basket trial of ODM-212, an oral pan TEAD inhibitor. The study targets patients with advanced cancers, including mesothelioma, KRAS G12C mutated non small cell lung cancer, and pancreatic cancer. The trial initiation marks a new clinical step for Orion Oyj in oncology research. For investors watching HLSE:ORNBV, this new trial adds a fresh clinical asset to an already established pharma business. The share price is currently €68.7, with the stock up 3.1%...

Q1 results and reiterated 2026 guidance Kesko Oyj (HLSE:KESKOB) caught investor attention after reporting first quarter 2026 results along with reiterated full year earnings guidance, tying recent performance to management’s expectations for profit and operating conditions. For the first quarter, Kesko reported sales of €3,029 million compared with €2,827.7 million a year earlier, with net income of €51.3 million versus €48.4 million and basic earnings per share steady at €0.13. The company...

If you are wondering whether Nokia Oyj is priced attractively today, the recent share performance gives you plenty of reasons to take a closer look. The stock last closed at €10.61, with returns of 18.5% over 7 days, 44.3% over 30 days, 92.0% year to date and 147.5% over 1 year. This frames an important backdrop for any valuation work you do next. Recent coverage has focused on Nokia Oyj as a key name in the communications technology space and on how investors are reassessing established...

It's shaping up to be a tough period for Metsä Board Oyj ( HEL:METSB ), which a week ago released some disappointing...

Konecranes Plc ( HEL:KCR ) just released its latest first-quarter report and things are not looking great. It wasn't a...

Shareholders might have noticed that KONE Oyj ( HEL:KNEBV ) filed its first-quarter result this time last week. The...

It looks like NoHo Partners Oyj ( HEL:NOHO ) is about to go ex-dividend in the next four days. The ex-dividend date is...

Aktia Pankki Oyj (HLSE:AKTIA) has opened 2026 with a mixed picture, heading into Q1 on the back of Q4 2025 revenue of €69.1 million and a basic EPS loss of €0.68, while trailing 12 month EPS stood at €0.14 alongside total revenue of €280.0 million. Over recent quarters, revenue has moved from €74.1 million in Q4 2024 to €70.7 million in Q1 2025 and €70.1 million in both Q2 and Q3 2025, as EPS swung from a marginal loss of €0.00 in Q4 2024 to quarterly profits of €0.30, €0.25 and €0.27 before...

Bittium Oyj (HLSE:BITTI) has caught investor attention after reiterating its 2026 earnings guidance and pairing that outlook with a proposed extraordinary dividend of €0.15 per share, subject to board confirmation. See our latest analysis for Bittium Oyj. Despite the guidance and extraordinary dividend announcement, the share price has been under pressure recently, with a 1 month share price return of 18.82% and a 3 month share price return of 15.69%, while the year to date share price return...